Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JPM 2018
Biotech
Aimmune details egg, milk allergy programs
Aimmune CEO Stephen Dilly discussed allergy immunotherapies and shed light on why it takes so long to create a starting dose.
Amirah Al Idrus
Jan 11, 2018 11:12am
Report from the front line: FierceBiotech's JPM Executive Breakfast
Jan 10, 2018 8:35am
FierceBiotech’s #JPM18 live blog
Jan 10, 2018 7:05am
Hung out to dry? Axovant’s terrible JPM week
Jan 10, 2018 5:43am
After $270M round, BioNTech pens TCR pact with Scancell
Jan 9, 2018 10:30am
In it for the long haul: A chat with Barry Greene
Jan 9, 2018 10:20am
